Clinical Trial Update: A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

View source ↗

Summary

A completed prospective observational trial evaluating the lipid-lowering effect, changes in glucose metabolism, and safety of Atostazet in hypercholesterolemic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Atostazet (Atostazet)

Snippet

Sponsor: Dong Wha Pharmaceutical Co. Ltd. | Conditions: Hypercholesterolemia | Status: COMPLETED